Flexion Therapeutics to Report First-Quarter 2021 Financial Results on May 12, 2021

Rhea-AI Summary

Flexion Therapeutics (Nasdaq:FLXN) will announce its first-quarter 2021 financial results on May 12, 2021, after U.S. market close. A live webcast of the conference call will be accessible via the company’s website, with a replay available afterward. Interested participants can dial in using the provided numbers for domestic and international callers. Flexion focuses on developing innovative local therapies for musculoskeletal conditions, particularly osteoarthritis.

Positive

• Scheduled release of first quarter 2021 financial results indicates transparency and investor engagement.

Negative

• None.

News Market Reaction – FLXN

-0.94%

-0.94% Session move

In the trading session that priced this news, FLXN declined 0.94%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its first-quarter 2021 financial results after the close of the U.S. financial markets on Wednesday, May 12, 2021.

A live webcast of the conference call can be accessed through the “Investors” tab on the Flexion Therapeutics website, and a replay will be available online after the call. For those planning to ask a question, the dial-in number for the conference call is 855-770-0022 for domestic participants and 908-982-4677 for international participants, with Conference ID # 9786283. Please dial in at least 15 minutes in advance to ensure a timely connection to the call.

About Flexion Therapeutics
Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The company's core values are focus, ingenuity, tenacity, transparency and fun. Please visit flexiontherapeutics.com.

Contact:

Scott Young
Vice President, Corporate Communications & Investor Relations
T: 781-305-7194
syoung@flexiontherapeutics.com

FAQ

When will Flexion Therapeutics report its first quarter 2021 financial results?

Flexion Therapeutics will report its first quarter 2021 financial results on May 12, 2021, after the U.S. market close.

How can I access the Flexion Therapeutics conference call?

The conference call can be accessed via a live webcast on the Flexion Therapeutics website.

What is Flexion Therapeutics focused on?

Flexion Therapeutics is focused on developing novel local therapies for musculoskeletal conditions, particularly osteoarthritis.

What are the dial-in numbers for the Flexion Therapeutics conference call?

The dial-in number for domestic participants is 855-770-0022, and for international participants, it is 908-982-4677.

Is there a replay available for the conference call?

Yes, a replay of the conference call will be available online after the call.